Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human corneal epithelial GLUT-1 and glycocalyx components constitute the primary biochemical and physical interface of the ocular surface. GLUT-1, or Solute carrier family 2 member 1, is a uniporter protein responsible for the facilitated diffusion of glucose into corneal epithelial cells, ensuring metabolic support for the avascular cornea [PubMed: 10889430]. The glycocalyx is a dense network of membrane-associated mucins, such as MUC1, MUC4, and MUC16, which provide a hydrophilic environment that stabilizes the tear film and prevents pathogen adhesion [PubMed: 21846365]. This system is a major focus in ophthalmology because GLUT-1 can be exploited for the targeted delivery of glucose-conjugated prodrugs to improve drug penetration into the eye [PubMed: 23830730]. By mimicking natural substrates, these prodrugs utilize the transporter's mechanism to bypass the restrictive corneal barrier. Conversely, degradation or dysfunction of the glycocalyx components is a hallmark of dry eye disease and diabetic keratopathy, leading to increased susceptibility to infection and mechanical damage [PubMed: 15111340]. Therapeutic strategies often aim to either restore glycocalyx integrity or utilize the GLUT-1 pathway for efficient drug uptake.
Facilitated diffusion of glucose and glucose-conjugated prodrugs via GLUT1; maintenance of ocular surface hydration and pathogen defense via glycocalyx mucins.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 2 member 1 (GLUT1) and corneal glycocalyx components (GLUT1/Glycocalyx).